IONS:NASDAQ
Ionis Pharmaceuticals Inc
$47.25
arrow_downward
-8.15%(-4.19) 1D
$47.98
arrow_upward
+1.54% (+0.73)bedtimeAfter hours
Closed: Sep 15, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for IONS...
Open
$51.37
High
$51.37
Low
$46.72
Mkt. cap
7.85B
Avg. vol.
2.72M
Volume
6.81M
52-wk high
$86.74
52-wk low
$46.72
EPS
-$3.47
Beta
0.42
Shares outstanding
166.18M
No. of employees
1K
Open
$51.37
High
$51.37
Low
$46.72
Mkt. cap
7.85B
Avg. vol.
2.72M
Volume
6.81M
52-wk high
$86.74
52-wk low
$46.72
EPS
-$3.47
Beta
0.42
Shares outstanding
166.18M
No. of employees
1K
News stories
From web sources and news partners
Quiver Quantitative
·
6 hours ago
Why Ionis Pharmaceuticals (IONS) Stock Is Down Today
Investing.com
·
10 hours ago
Ionis Pharmaceuticals stock hits 52-week low at $50.00
Zacks
·
11 hours ago
PHVS Stock Rises 10% in a Month: What Is Driving the Rally?
Investing.com
·
13 hours ago
Guggenheim cuts Ionis Pharmaceuticals stock price target on sales outlook
Profile
Ionis Pharmaceuticals, Inc. is a biotechnology company that specializes in discovering and developing antisense therapy, as well as RNA interference and CRISPR therapeutics. The company was founded in 1989 is based in Carlsbad, California. The company was previously known as Isis Pharmaceuticals until December 2015. Wikipedia
About Ionis Pharmaceuticals Inc
CEOBrett P. Monia Ph.D.
Employees1.48K
Founded1989
HeadquartersCarlsbad, California, United States
SectorBiotechnology
Websiteionis.com